Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

CIT 013

Next Previous
Drug Profile

CIT 013

Alternative Names: CIT-013; tACPA therapeutic antibody - Citryll; Therapeutic anti-citrullinated protein antibodies - Citryll

Latest Information Update: 11 Jun 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator ModiQuest Research
  • Developer Citryll
  • Class Anti-inflammatories; Antibodies; Antifibrotics; Antirheumatics; Monoclonal antibodies; Vascular disorder therapies
  • Mechanism of Action Extracellular trap inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Rheumatoid arthritis

Most Recent Events

  • 28 May 2025 Citryll plans a phase IIa trial for Hidradenitis Suppurativa (Treatment -experienced) inthe Netherlands (SC, Injection) in September 2025 (NCT06993233)
  • 20 Feb 2025 Pharmacodynamics data from preclinical studies in Inflammatory disorders released by Citryll
  • 04 Dec 2024 Citryll plans a phase IIa trial in Rheumatoid arthritis in Q2 2025 (Citryll pipeline, December 2024)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top